PP
Pierre-Yves Poirier
OtherActivePartner at Andera Partners
83
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Pierre-Yves Poirier.
Investment Thesis & Strategy
Andera Partners invests in various stages across biotech, SaaS, consumer internet, healthcare, and energytech, seeking to partner with innovative companies with high growth potential.
Portfolio Companies
Selected investments from their portfolio of 83 companies
L
La Toulousaine
Other · , 0
T
T-knife
Biotech · Series A, 0
E
Endosense
Healthcare · Series B, 0
P
Poxel
Biotech · Series A, 0
H
HR Path
Enterprise · Growth, 0
A
Axonics Modulation Technologies
Healthcare · Series C+, 0
L
La Vie Saine
Food & Beverage · Seed, 0
S
Sfam
Fintech · Growth, 0
M
Mondial Pet Distribution
Consumer · Seed, 0
S
Sirsa
Other · Seed, 0
R
ReViral
Biotech · Series A, 0
I
In'Tech Medical
Healthcare · Seed, 0
Frequently Asked Questions
Pierre-Yves Poirier focuses on Series B stage investments.